CANTHARIDIN 0.7%- cantharidin 0.7% liquid 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

CANTHARIDIN 0.7%

Directions for use

sdgf

Sincerus Florida, LLC. Adverse reactions

ad

Active, inactive

azsd

NDC 72934- 9035-9 CANTHARIDIN 0.7%. Liquid 15 gm

ad

CANTHARIDIN 0.7% 
cantharidin 0.7% liquid
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-9035
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CANTHARIDIN (UNII: IGL471WQ8P) (CANTHARIDIN - UNII:IGL471WQ8P) CANTHARIDIN0.7 g  in 100 g
Product Characteristics
Colorwhite (clear liquid) Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-9035-915 g in 1 VIAL; Type 0: Not a Combination Product05/17/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/17/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-9035)

Revised: 5/2019
Document Id: 891ae88b-bacd-137f-e053-2a95a90a8f7d
Set id: 891ae88b-bacc-137f-e053-2a95a90a8f7d
Version: 1
Effective Time: 20190517
 
Sincerus Florida, LLC